Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells
- 25 October 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (50) , 7730-7739
- https://doi.org/10.1038/sj.onc.1205971
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 43 references indexed in Scilit:
- VEGF165 requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cellsOncogene, 2001
- Role of direct interaction in BRCA1 inhibition of estrogen receptor activityOncogene, 2001
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- Angiogenesis in endocrine-related cancersEndocrine-Related Cancer, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular MatrixJournal of Biological Chemistry, 1997
- The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic PotencyJournal of Biological Chemistry, 1996
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene familyBiochemical and Biophysical Research Communications, 1989